NCT03589651 2023-02-21INCMGA00012 in Combination With Other Therapies in Patients With Advanced Solid TumorsIncyte CorporationPhase 1 Completed83 enrolled
NCT03277352 2021-07-22INCAGN01876 in Combination With Immune Therapies in Subjects With Advanced or Metastatic MalignanciesIncyte CorporationPhase 1/2 Terminated10 enrolled 14 charts
NCT02559492 2019-09-25Itacitinib Combined With INCB024360 and/or Itacitinib Combined With INCB050465 in Advanced Solid TumorsIncyte CorporationPhase 1 Terminated142 enrolled